Aperio Group’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$752K Buy
28,753
+3,876
+16% +$101K ﹤0.01% 1750
2020
Q3
$433K Sell
24,877
-3,985
-14% -$69.4K ﹤0.01% 1890
2020
Q2
$485K Buy
28,862
+5,098
+21% +$85.7K ﹤0.01% 1793
2020
Q1
$283K Buy
23,764
+2,982
+14% +$35.5K ﹤0.01% 1938
2019
Q4
$251K Sell
20,782
-1,984
-9% -$24K ﹤0.01% 2119
2019
Q3
$322K Buy
22,766
+9,142
+67% +$129K ﹤0.01% 1985
2019
Q2
$152K Buy
13,624
+2,460
+22% +$27.4K ﹤0.01% 2268
2019
Q1
$131K Sell
11,164
-11,708
-51% -$137K ﹤0.01% 2222
2018
Q4
$306K Buy
22,872
+8,351
+58% +$112K ﹤0.01% 1933
2018
Q3
$203K Sell
14,521
-587
-4% -$8.21K ﹤0.01% 2183
2018
Q2
$238K Buy
15,108
+109
+0.7% +$1.72K ﹤0.01% 2099
2018
Q1
$246K Buy
+14,999
New +$246K ﹤0.01% 2043